

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 5.38772065 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.38772065 |
| 3 | protein targeting to Golgi (GO:0000042) | 4.29167179 |
| 4 | establishment of protein localization to Golgi (GO:0072600) | 4.05442147 |
| 5 | COPII vesicle coating (GO:0048208) | 3.93690076 |
| 6 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.92353492 |
| 7 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.85178447 |
| 8 | macroautophagy (GO:0016236) | 3.80740552 |
| 9 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.65092483 |
| 10 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.57951283 |
| 11 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.45369715 |
| 12 | exocrine pancreas development (GO:0031017) | 3.38477732 |
| 13 | histone H3-K4 trimethylation (GO:0080182) | 3.37090371 |
| 14 | positive regulation of nuclease activity (GO:0032075) | 3.35737383 |
| 15 | vesicle coating (GO:0006901) | 3.28390879 |
| 16 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.27191286 |
| 17 | protein localization to Golgi apparatus (GO:0034067) | 3.13177696 |
| 18 | fibroblast migration (GO:0010761) | 3.11205729 |
| 19 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.09217458 |
| 20 | desmosome organization (GO:0002934) | 3.08307675 |
| 21 | interkinetic nuclear migration (GO:0022027) | 3.06422552 |
| 22 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.06076195 |
| 23 | peptide hormone processing (GO:0016486) | 3.04816763 |
| 24 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.03733939 |
| 25 | pericardium development (GO:0060039) | 3.00240228 |
| 26 | auditory receptor cell differentiation (GO:0042491) | 2.98842835 |
| 27 | regulation of nuclease activity (GO:0032069) | 2.97889076 |
| 28 | ER-nucleus signaling pathway (GO:0006984) | 2.97371012 |
| 29 | ER overload response (GO:0006983) | 2.97185480 |
| 30 | protein retention in ER lumen (GO:0006621) | 2.96365420 |
| 31 | cellular response to unfolded protein (GO:0034620) | 2.93799730 |
| 32 | protein targeting to vacuole (GO:0006623) | 2.93790177 |
| 33 | protein targeting to lysosome (GO:0006622) | 2.93790177 |
| 34 | establishment of protein localization to vacuole (GO:0072666) | 2.93790177 |
| 35 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.92498795 |
| 36 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.89790156 |
| 37 | endocrine pancreas development (GO:0031018) | 2.88375856 |
| 38 | insulin secretion (GO:0030073) | 2.84393999 |
| 39 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.83198900 |
| 40 | early endosome to late endosome transport (GO:0045022) | 2.80282712 |
| 41 | inner ear receptor cell development (GO:0060119) | 2.70409198 |
| 42 | cellular response to topologically incorrect protein (GO:0035967) | 2.70213879 |
| 43 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.68923420 |
| 44 | iron ion import (GO:0097286) | 2.68488668 |
| 45 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.68386377 |
| 46 | type B pancreatic cell development (GO:0003323) | 2.65037584 |
| 47 | regulation of establishment of cell polarity (GO:2000114) | 2.64950584 |
| 48 | peptidyl-lysine trimethylation (GO:0018023) | 2.64101355 |
| 49 | Golgi to endosome transport (GO:0006895) | 2.63669347 |
| 50 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.61385627 |
| 51 | regulation of pigment cell differentiation (GO:0050932) | 2.61381128 |
| 52 | positive regulation of glycolytic process (GO:0045821) | 2.57914979 |
| 53 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.57265843 |
| 54 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.57146208 |
| 55 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.55681856 |
| 56 | response to endoplasmic reticulum stress (GO:0034976) | 2.54090890 |
| 57 | detection of calcium ion (GO:0005513) | 2.53547250 |
| 58 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.52691513 |
| 59 | stress granule assembly (GO:0034063) | 2.52457098 |
| 60 | regulation of RNA export from nucleus (GO:0046831) | 2.50178543 |
| 61 | positive regulation of histone deacetylation (GO:0031065) | 2.49449515 |
| 62 | endocrine hormone secretion (GO:0060986) | 2.48123152 |
| 63 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.46222767 |
| 64 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.44889967 |
| 65 | smooth muscle tissue development (GO:0048745) | 2.41294826 |
| 66 | nucleus localization (GO:0051647) | 2.40946948 |
| 67 | relaxation of cardiac muscle (GO:0055119) | 2.40364440 |
| 68 | phospholipid translocation (GO:0045332) | 2.40015308 |
| 69 | regulation of ARF protein signal transduction (GO:0032012) | 2.39658871 |
| 70 | glandular epithelial cell development (GO:0002068) | 2.39207630 |
| 71 | histone H3-K9 demethylation (GO:0033169) | 2.38938493 |
| 72 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.37476807 |
| 73 | hemidesmosome assembly (GO:0031581) | 2.37457393 |
| 74 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.37380217 |
| 75 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.37178259 |
| 76 | peptidyl-lysine methylation (GO:0018022) | 2.35322733 |
| 77 | cellular response to ethanol (GO:0071361) | 2.34364858 |
| 78 | embryonic foregut morphogenesis (GO:0048617) | 2.34226461 |
| 79 | sequestering of metal ion (GO:0051238) | 2.34071649 |
| 80 | endoplasmic reticulum organization (GO:0007029) | 2.33579821 |
| 81 | growth hormone receptor signaling pathway (GO:0060396) | 2.33246882 |
| 82 | regulation of protein polyubiquitination (GO:1902914) | 2.32172833 |
| 83 | Golgi to plasma membrane transport (GO:0006893) | 2.30896355 |
| 84 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.30886267 |
| 85 | branching involved in prostate gland morphogenesis (GO:0060442) | 2.30250667 |
| 86 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.30003481 |
| 87 | genitalia morphogenesis (GO:0035112) | 2.29063154 |
| 88 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.28706562 |
| 89 | positive regulation of p38MAPK cascade (GO:1900745) | 2.28478807 |
| 90 | response to unfolded protein (GO:0006986) | 2.28195167 |
| 91 | artery development (GO:0060840) | 2.27885142 |
| 92 | positive regulation of glycogen metabolic process (GO:0070875) | 2.27092457 |
| 93 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.26769692 |
| 94 | activation of protein kinase A activity (GO:0034199) | 2.26767030 |
| 95 | * Golgi organization (GO:0007030) | 2.26675982 |
| 96 | glandular epithelial cell differentiation (GO:0002067) | 2.26358425 |
| 97 | regulation of insulin secretion (GO:0050796) | 2.26126295 |
| 98 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.25024565 |
| 99 | coronary vasculature morphogenesis (GO:0060977) | 2.25000072 |
| 100 | mitotic sister chromatid cohesion (GO:0007064) | 2.24965653 |
| 101 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.24601729 |
| 102 | 4-hydroxyproline metabolic process (GO:0019471) | 2.24379688 |
| 103 | regulation of insulin-like growth factor receptor signaling pathway (GO:0043567) | 2.24088472 |
| 104 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.23641066 |
| 105 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.23469855 |
| 106 | apical protein localization (GO:0045176) | 2.23194192 |
| 107 | ear development (GO:0043583) | 2.23169389 |
| 108 | cellular response to vitamin D (GO:0071305) | 2.22551531 |
| 109 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.22481342 |
| 110 | negative regulation of complement activation (GO:0045916) | 2.22452240 |
| 111 | Sertoli cell development (GO:0060009) | 2.22006762 |
| 112 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.21350812 |
| 113 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.20714378 |
| 114 | toxin transport (GO:1901998) | 2.20665409 |
| 115 | intestinal cholesterol absorption (GO:0030299) | 2.20002884 |
| 116 | peptide secretion (GO:0002790) | 2.19937335 |
| 117 | apoptotic cell clearance (GO:0043277) | 2.19777325 |
| 118 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.19703784 |
| 119 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.19428484 |
| 120 | cellular response to vitamin (GO:0071295) | 2.18312087 |
| 121 | positive regulation of insulin secretion (GO:0032024) | 2.18160054 |
| 122 | protein K48-linked deubiquitination (GO:0071108) | 2.17866782 |
| 123 | carnitine transmembrane transport (GO:1902603) | 2.17841008 |
| 124 | regulation of protein glycosylation (GO:0060049) | 2.17268295 |
| 125 | carnitine transport (GO:0015879) | 2.16431524 |
| 126 | amino-acid betaine transport (GO:0015838) | 2.16431524 |
| 127 | face morphogenesis (GO:0060325) | 2.16407230 |
| 128 | Golgi to plasma membrane protein transport (GO:0043001) | 2.15957494 |
| 129 | negative regulation of protein activation cascade (GO:2000258) | 2.15748444 |
| 130 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.15166202 |
| 131 | mannose metabolic process (GO:0006013) | 2.14913798 |
| 132 | cilium movement (GO:0003341) | 2.14780979 |
| 133 | response to topologically incorrect protein (GO:0035966) | 2.13843271 |
| 134 | establishment of nucleus localization (GO:0040023) | 2.13725188 |
| 135 | protein maturation by protein folding (GO:0022417) | 2.13304822 |
| 136 | chemosensory behavior (GO:0007635) | 2.13213972 |
| 137 | carnitine shuttle (GO:0006853) | 2.12563549 |
| 138 | positive regulation of vesicle fusion (GO:0031340) | 2.12260434 |
| 139 | toxin metabolic process (GO:0009404) | 2.11962587 |
| 140 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.11749668 |
| 141 | peptide hormone secretion (GO:0030072) | 2.10879346 |
| 142 | plasma membrane repair (GO:0001778) | 2.10549850 |
| 143 | inositol phosphate-mediated signaling (GO:0048016) | 2.10382464 |
| 144 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.10182112 |
| 145 | negative regulation of fatty acid transport (GO:2000192) | 2.10095189 |
| 146 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.09954591 |
| 147 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.08219724 |
| 148 | semaphorin-plexin signaling pathway (GO:0071526) | 2.07443546 |
| 149 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.06895148 |
| 150 | regulation of polysaccharide biosynthetic process (GO:0032885) | 2.06835663 |
| 151 | transcytosis (GO:0045056) | 2.06533270 |
| 152 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.06499260 |
| 153 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.05969779 |
| 154 | cellular response to growth hormone stimulus (GO:0071378) | 2.05793532 |
| 155 | regulation of glycogen biosynthetic process (GO:0005979) | 2.05781199 |
| 156 | regulation of glucan biosynthetic process (GO:0010962) | 2.05781199 |
| 157 | collagen fibril organization (GO:0030199) | 2.05643618 |
| 158 | intestinal epithelial cell development (GO:0060576) | 2.04582223 |
| 159 | regulation of keratinocyte proliferation (GO:0010837) | 2.04577086 |
| 160 | regulation of peptide hormone secretion (GO:0090276) | 2.04018932 |
| 161 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.03870233 |
| 162 | phospholipid homeostasis (GO:0055091) | 2.03029953 |
| 163 | hormone catabolic process (GO:0042447) | 2.02441712 |
| 164 | cerebellar Purkinje cell layer development (GO:0021680) | 2.02426938 |
| 165 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.02366705 |
| 166 | negative regulation of glycogen metabolic process (GO:0070874) | 2.01553188 |
| 167 | endocardial cushion development (GO:0003197) | 2.01410442 |
| 168 | regulation of peptide secretion (GO:0002791) | 2.01330706 |
| 169 | import into cell (GO:0098657) | 2.01268797 |
| 170 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.01011406 |
| 171 | nerve growth factor signaling pathway (GO:0038180) | 2.00145464 |
| 172 | acrosome assembly (GO:0001675) | 1.99878699 |
| 173 | regulation of cholesterol homeostasis (GO:2000188) | 1.99071957 |
| 174 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 1.99008389 |
| 175 | Leydig cell differentiation (GO:0033327) | 1.98876902 |
| 176 | regulation of fatty acid beta-oxidation (GO:0031998) | 1.98391535 |
| 177 | negative regulation of hormone metabolic process (GO:0032351) | 1.98359834 |
| 178 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 1.98267525 |
| 179 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 1.98267525 |
| 180 | regulation of translation, ncRNA-mediated (GO:0045974) | 1.98267525 |
| 181 | chondrocyte development (GO:0002063) | 1.97500453 |
| 182 | vesicle transport along microtubule (GO:0047496) | 1.97104224 |
| 183 | lipid translocation (GO:0034204) | 1.95498921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.09711653 |
| 2 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.15106008 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.12410202 |
| 4 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.96618574 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 1.95158606 |
| 6 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.89351694 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.88842463 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.82740949 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73966451 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.71742375 |
| 11 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.69026553 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.68053527 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.66615369 |
| 14 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.66142703 |
| 15 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.62977990 |
| 16 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.61213276 |
| 17 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.58413652 |
| 18 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54648844 |
| 19 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.54350248 |
| 20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51097963 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.50872206 |
| 22 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.49411614 |
| 23 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.49322609 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.47724011 |
| 25 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.46423111 |
| 26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44142367 |
| 27 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.42633168 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.41909695 |
| 29 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41531840 |
| 30 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40959868 |
| 31 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.40722619 |
| 32 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.37304937 |
| 33 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.37304937 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35243612 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.33905953 |
| 36 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.33593920 |
| 37 | STAT3_23295773_ChIP-Seq_U87_Human | 1.33215293 |
| 38 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.32183175 |
| 39 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.30463176 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30454764 |
| 41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.29912959 |
| 42 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.29328806 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27555704 |
| 44 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27292774 |
| 45 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27141606 |
| 46 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.27125846 |
| 47 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.26114750 |
| 48 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25964776 |
| 49 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25375276 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23865271 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.23361440 |
| 52 | TP53_16413492_ChIP-PET_HCT116_Human | 1.23354158 |
| 53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22647142 |
| 54 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22437304 |
| 55 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.22037610 |
| 56 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.21779534 |
| 57 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18693956 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18642273 |
| 59 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.18023132 |
| 60 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17660373 |
| 61 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.17013738 |
| 62 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.16234361 |
| 63 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16218733 |
| 64 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.16072732 |
| 65 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15936643 |
| 66 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.14925985 |
| 67 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14027157 |
| 68 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.13717563 |
| 69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.13347294 |
| 70 | AR_19668381_ChIP-Seq_PC3_Human | 1.13284111 |
| 71 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.13177491 |
| 72 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.12985282 |
| 73 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.12588907 |
| 74 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12180218 |
| 75 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.12106177 |
| 76 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12019280 |
| 77 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10877970 |
| 78 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.10203934 |
| 79 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09478219 |
| 80 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07995746 |
| 81 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.07986995 |
| 82 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07397013 |
| 83 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.06553696 |
| 84 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.06371088 |
| 85 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.05772788 |
| 86 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.05683691 |
| 87 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.05318848 |
| 88 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04295651 |
| 89 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.04004952 |
| 90 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03933951 |
| 91 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.02883130 |
| 92 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02621387 |
| 93 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02000100 |
| 94 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01995216 |
| 95 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.01827498 |
| 96 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01548572 |
| 97 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01366070 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01256973 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01256973 |
| 100 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00328026 |
| 101 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.00161947 |
| 102 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.00028517 |
| 103 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99960970 |
| 104 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99722458 |
| 105 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.99720124 |
| 106 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99256001 |
| 107 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98732897 |
| 108 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98600344 |
| 109 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98600344 |
| 110 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.98483310 |
| 111 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98203529 |
| 112 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98203529 |
| 113 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98128958 |
| 114 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98128958 |
| 115 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97584727 |
| 116 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96816346 |
| 117 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96092351 |
| 118 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96092351 |
| 119 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.95964397 |
| 120 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95897221 |
| 121 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95875298 |
| 122 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95500060 |
| 123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94017266 |
| 124 | KDM2B_26808549_Chip-Seq_K562_Human | 0.93827442 |
| 125 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93100130 |
| 126 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.92900579 |
| 127 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92269991 |
| 128 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91408486 |
| 129 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.91175862 |
| 130 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90227296 |
| 131 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.90065768 |
| 132 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88285925 |
| 133 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86586523 |
| 134 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.86223931 |
| 135 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 0.85587229 |
| 136 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.85446321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009780_abnormal_chondrocyte_physiolo | 4.56461311 |
| 2 | MP0000569_abnormal_digit_pigmentation | 3.43755669 |
| 3 | MP0003283_abnormal_digestive_organ | 3.20684178 |
| 4 | MP0002909_abnormal_adrenal_gland | 3.16729385 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 2.99083673 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 2.95428027 |
| 7 | MP0000013_abnormal_adipose_tissue | 2.80673545 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.78631633 |
| 9 | MP0004043_abnormal_pH_regulation | 2.61900885 |
| 10 | MP0003252_abnormal_bile_duct | 2.46698437 |
| 11 | MP0003183_abnormal_peptide_metabolism | 2.33651755 |
| 12 | MP0003045_fibrosis | 2.32699553 |
| 13 | MP0002693_abnormal_pancreas_physiology | 2.31461300 |
| 14 | MP0001944_abnormal_pancreas_morphology | 2.30486081 |
| 15 | MP0005409_darkened_coat_color | 2.23307331 |
| 16 | MP0003195_calcinosis | 2.20171980 |
| 17 | MP0005365_abnormal_bile_salt | 2.17380236 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.16976847 |
| 19 | MP0003890_abnormal_embryonic-extraembry | 2.10872864 |
| 20 | MP0000383_abnormal_hair_follicle | 2.10786087 |
| 21 | MP0010386_abnormal_urinary_bladder | 2.09534899 |
| 22 | MP0004264_abnormal_extraembryonic_tissu | 2.09149113 |
| 23 | MP0000003_abnormal_adipose_tissue | 2.06921231 |
| 24 | MP0010678_abnormal_skin_adnexa | 1.90663842 |
| 25 | MP0008057_abnormal_DNA_replication | 1.88251961 |
| 26 | MP0002139_abnormal_hepatobiliary_system | 1.78114659 |
| 27 | MP0008438_abnormal_cutaneous_collagen | 1.75235960 |
| 28 | MP0002896_abnormal_bone_mineralization | 1.73260948 |
| 29 | MP0005220_abnormal_exocrine_pancreas | 1.72094724 |
| 30 | MP0002078_abnormal_glucose_homeostasis | 1.71041941 |
| 31 | MP0005379_endocrine/exocrine_gland_phen | 1.67958455 |
| 32 | MP0005670_abnormal_white_adipose | 1.65127348 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.62499167 |
| 34 | MP0008961_abnormal_basal_metabolism | 1.59071489 |
| 35 | MP0005375_adipose_tissue_phenotype | 1.51679839 |
| 36 | MP0001299_abnormal_eye_distance/ | 1.49004596 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.45385634 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.43675216 |
| 39 | MP0003868_abnormal_feces_composition | 1.40079289 |
| 40 | MP0001502_abnormal_circadian_rhythm | 1.39551082 |
| 41 | MP0001666_abnormal_nutrient_absorption | 1.38538290 |
| 42 | MP0002168_other_aberrant_phenotype | 1.35847855 |
| 43 | MP0001879_abnormal_lymphatic_vessel | 1.34557107 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.33539028 |
| 45 | MP0001765_abnormal_ion_homeostasis | 1.33473263 |
| 46 | MP0004130_abnormal_muscle_cell | 1.32997325 |
| 47 | MP0005085_abnormal_gallbladder_physiolo | 1.29517898 |
| 48 | MP0005275_abnormal_skin_tensile | 1.29471286 |
| 49 | MP0002928_abnormal_bile_duct | 1.28899165 |
| 50 | MP0000427_abnormal_hair_cycle | 1.24598360 |
| 51 | MP0003122_maternal_imprinting | 1.23363071 |
| 52 | MP0005187_abnormal_penis_morphology | 1.23292180 |
| 53 | MP0005666_abnormal_adipose_tissue | 1.23288507 |
| 54 | MP0004270_analgesia | 1.21563563 |
| 55 | MP0010329_abnormal_lipoprotein_level | 1.19485581 |
| 56 | MP0004185_abnormal_adipocyte_glucose | 1.18793719 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.18501526 |
| 58 | MP0004272_abnormal_basement_membrane | 1.16562541 |
| 59 | MP0000678_abnormal_parathyroid_gland | 1.15779528 |
| 60 | MP0001958_emphysema | 1.15573979 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.14777218 |
| 62 | MP0002234_abnormal_pharynx_morphology | 1.13075597 |
| 63 | MP0005248_abnormal_Harderian_gland | 1.12035841 |
| 64 | MP0003787_abnormal_imprinting | 1.10746004 |
| 65 | MP0000767_abnormal_smooth_muscle | 1.10021916 |
| 66 | MP0005535_abnormal_body_temperature | 1.08023600 |
| 67 | MP0003937_abnormal_limbs/digits/tail_de | 1.07990210 |
| 68 | MP0000462_abnormal_digestive_system | 1.07580686 |
| 69 | MP0003121_genomic_imprinting | 1.04493166 |
| 70 | MP0005058_abnormal_lysosome_morphology | 1.04136211 |
| 71 | MP0000534_abnormal_ureter_morphology | 1.03979340 |
| 72 | MP0005257_abnormal_intraocular_pressure | 1.03333024 |
| 73 | MP0003953_abnormal_hormone_level | 1.01654417 |
| 74 | MP0002109_abnormal_limb_morphology | 1.00917139 |
| 75 | MP0002118_abnormal_lipid_homeostasis | 1.00834871 |
| 76 | MP0003942_abnormal_urinary_system | 1.00488305 |
| 77 | MP0005448_abnormal_energy_balance | 1.00082874 |
| 78 | MP0005310_abnormal_salivary_gland | 0.99493206 |
| 79 | MP0000432_abnormal_head_morphology | 0.99182527 |
| 80 | MP0005408_hypopigmentation | 0.99141751 |
| 81 | MP0001661_extended_life_span | 0.96575206 |
| 82 | MP0005334_abnormal_fat_pad | 0.96404854 |
| 83 | MP0003935_abnormal_craniofacial_develop | 0.95628851 |
| 84 | MP0000428_abnormal_craniofacial_morphol | 0.94633532 |
| 85 | MP0004134_abnormal_chest_morphology | 0.94596774 |
| 86 | MP0005023_abnormal_wound_healing | 0.94241462 |
| 87 | MP0002115_abnormal_skeleton_extremities | 0.93464861 |
| 88 | MP0004084_abnormal_cardiac_muscle | 0.91766973 |
| 89 | MP0008877_abnormal_DNA_methylation | 0.91429558 |
| 90 | MP0003755_abnormal_palate_morphology | 0.91313684 |
| 91 | MP0004859_abnormal_synaptic_plasticity | 0.91211193 |
| 92 | MP0003936_abnormal_reproductive_system | 0.91029886 |
| 93 | MP0006072_abnormal_retinal_apoptosis | 0.90677413 |
| 94 | MP0000778_abnormal_nervous_system | 0.89997638 |
| 95 | MP0001756_abnormal_urination | 0.89995728 |
| 96 | MP0005645_abnormal_hypothalamus_physiol | 0.89360802 |
| 97 | MP0003115_abnormal_respiratory_system | 0.88604298 |
| 98 | MP0005360_urolithiasis | 0.88162354 |
| 99 | MP0002009_preneoplasia | 0.88101288 |
| 100 | MP0000371_diluted_coat_color | 0.87580067 |
| 101 | MP0005646_abnormal_pituitary_gland | 0.87356176 |
| 102 | MP0002108_abnormal_muscle_morphology | 0.85346941 |
| 103 | MP0002295_abnormal_pulmonary_circulatio | 0.85175019 |
| 104 | MP0000627_abnormal_mammary_gland | 0.84994191 |
| 105 | MP0006138_congestive_heart_failure | 0.84741057 |
| 106 | MP0000538_abnormal_urinary_bladder | 0.83381756 |
| 107 | MP0008875_abnormal_xenobiotic_pharmacok | 0.82745402 |
| 108 | MP0002925_abnormal_cardiovascular_devel | 0.82563125 |
| 109 | MP0003941_abnormal_skin_development | 0.82265385 |
| 110 | MP0002971_abnormal_brown_adipose | 0.81617891 |
| 111 | MP0003385_abnormal_body_wall | 0.81523427 |
| 112 | MP0003566_abnormal_cell_adhesion | 0.80949171 |
| 113 | MP0009643_abnormal_urine_homeostasis | 0.79495408 |
| 114 | MP0009384_cardiac_valve_regurgitation | 0.79431826 |
| 115 | MP0001177_atelectasis | 0.77639816 |
| 116 | MP0003279_aneurysm | 0.75349406 |
| 117 | MP0004085_abnormal_heartbeat | 0.74775166 |
| 118 | MP0005503_abnormal_tendon_morphology | 0.74697821 |
| 119 | MP0009115_abnormal_fat_cell | 0.74163872 |
| 120 | MP0000377_abnormal_hair_follicle | 0.73316295 |
| 121 | MP0002116_abnormal_craniofacial_bone | 0.72846004 |
| 122 | MP0004145_abnormal_muscle_electrophysio | 0.72814652 |
| 123 | MP0002233_abnormal_nose_morphology | 0.72725652 |
| 124 | MP0000613_abnormal_salivary_gland | 0.72202893 |
| 125 | MP0003959_abnormal_lean_body | 0.71711332 |
| 126 | MP0000516_abnormal_urinary_system | 0.70950346 |
| 127 | MP0005367_renal/urinary_system_phenotyp | 0.70950346 |
| 128 | MP0009703_decreased_birth_body | 0.70768639 |
| 129 | MP0002166_altered_tumor_susceptibility | 0.70481401 |
| 130 | MP0002138_abnormal_hepatobiliary_system | 0.70017876 |
| 131 | MP0002060_abnormal_skin_morphology | 0.69162529 |
| 132 | MP0004036_abnormal_muscle_relaxation | 0.69085837 |
| 133 | MP0000266_abnormal_heart_morphology | 0.69061035 |
| 134 | MP0001270_distended_abdomen | 0.68951179 |
| 135 | MP0000639_abnormal_adrenal_gland | 0.68350089 |
| 136 | MP0003091_abnormal_cell_migration | 0.68011186 |
| 137 | MP0002084_abnormal_developmental_patter | 0.67753373 |
| 138 | MP0002098_abnormal_vibrissa_morphology | 0.67426290 |
| 139 | MP0005508_abnormal_skeleton_morphology | 0.66679909 |
| 140 | MP0000609_abnormal_liver_physiology | 0.66487608 |
| 141 | MP0002090_abnormal_vision | 0.65647836 |
| 142 | MP0005164_abnormal_response_to | 0.65198627 |
| 143 | MP0002128_abnormal_blood_circulation | 0.65127738 |
| 144 | MP0010352_gastrointestinal_tract_polyps | 0.65061763 |
| 145 | MP0006054_spinal_hemorrhage | 0.64097755 |
| 146 | MP0000230_abnormal_systemic_arterial | 0.63500731 |
| 147 | MP0003633_abnormal_nervous_system | 0.63323449 |
| 148 | MP0005623_abnormal_meninges_morphology | 0.62713483 |
| 149 | MP0004233_abnormal_muscle_weight | 0.62427232 |
| 150 | MP0000751_myopathy | 0.62315617 |
| 151 | MP0002269_muscular_atrophy | 0.59938703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.88461510 |
| 2 | Hypoglycemic seizures (HP:0002173) | 4.47832666 |
| 3 | Hypoglycemic coma (HP:0001325) | 4.02497561 |
| 4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.96672993 |
| 5 | Symptomatic seizures (HP:0011145) | 3.87407306 |
| 6 | Hyperglycemia (HP:0003074) | 3.75351099 |
| 7 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.53342267 |
| 8 | Macroorchidism (HP:0000053) | 3.28813244 |
| 9 | Ketoacidosis (HP:0001993) | 3.08650948 |
| 10 | Overgrowth (HP:0001548) | 3.05750505 |
| 11 | Absent frontal sinuses (HP:0002688) | 2.91002836 |
| 12 | Vertebral arch anomaly (HP:0008438) | 2.77770249 |
| 13 | Hypoplastic ischia (HP:0003175) | 2.73821255 |
| 14 | Abnormality of the ischium (HP:0003174) | 2.73055975 |
| 15 | Abnormality of the intrinsic pathway (HP:0010989) | 2.64302519 |
| 16 | Aneurysm (HP:0002617) | 2.60348936 |
| 17 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.57850742 |
| 18 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.57850742 |
| 19 | Cerebral aneurysm (HP:0004944) | 2.55367086 |
| 20 | Tubulointerstitial nephritis (HP:0001970) | 2.50892274 |
| 21 | Decreased circulating renin level (HP:0003351) | 2.50757594 |
| 22 | Conjugated hyperbilirubinemia (HP:0002908) | 2.47453405 |
| 23 | Aortic dissection (HP:0002647) | 2.46871966 |
| 24 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.44130714 |
| 25 | Retinal atrophy (HP:0001105) | 2.39907080 |
| 26 | Abnormality of the nasal septum (HP:0000419) | 2.37174776 |
| 27 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.30903649 |
| 28 | Agitation (HP:0000713) | 2.30704649 |
| 29 | Skin nodule (HP:0200036) | 2.30392535 |
| 30 | Curly hair (HP:0002212) | 2.28806246 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27407290 |
| 32 | Mucopolysacchariduria (HP:0008155) | 2.27407290 |
| 33 | Hyperventilation (HP:0002883) | 2.26929881 |
| 34 | Protuberant abdomen (HP:0001538) | 2.24187712 |
| 35 | Abnormality of the common coagulation pathway (HP:0010990) | 2.22296607 |
| 36 | Hyperkalemia (HP:0002153) | 2.21011332 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16858749 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16858749 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16858749 |
| 40 | Turricephaly (HP:0000262) | 2.15977687 |
| 41 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.13797725 |
| 42 | Ketosis (HP:0001946) | 2.13609014 |
| 43 | Flat acetabular roof (HP:0003180) | 2.12338996 |
| 44 | Abdominal distention (HP:0003270) | 2.12254389 |
| 45 | Right ventricular cardiomyopathy (HP:0011663) | 2.07443863 |
| 46 | EEG with generalized epileptiform discharges (HP:0011198) | 2.05093267 |
| 47 | Abnormality of incisor morphology (HP:0011063) | 2.03823284 |
| 48 | Hypsarrhythmia (HP:0002521) | 2.03563383 |
| 49 | Limited hip movement (HP:0008800) | 2.00378351 |
| 50 | Abnormality of the renal cortex (HP:0011035) | 1.98038754 |
| 51 | Long toe (HP:0010511) | 1.97877637 |
| 52 | Lip pit (HP:0100267) | 1.97565230 |
| 53 | Hypokalemia (HP:0002900) | 1.97229065 |
| 54 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.97072617 |
| 55 | Epileptiform EEG discharges (HP:0011182) | 1.97068391 |
| 56 | Laryngomalacia (HP:0001601) | 1.96544085 |
| 57 | Hypoplastic labia majora (HP:0000059) | 1.95328231 |
| 58 | Late onset (HP:0003584) | 1.95204126 |
| 59 | Abnormal pancreas size (HP:0012094) | 1.94671054 |
| 60 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.93787589 |
| 61 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.93465445 |
| 62 | Atrophic scars (HP:0001075) | 1.93351701 |
| 63 | Thyroid carcinoma (HP:0002890) | 1.91573390 |
| 64 | Abnormality of potassium homeostasis (HP:0011042) | 1.90832570 |
| 65 | Bronchomalacia (HP:0002780) | 1.90638226 |
| 66 | Abnormality of the renal medulla (HP:0100957) | 1.89536926 |
| 67 | Large for gestational age (HP:0001520) | 1.88823121 |
| 68 | Papillary thyroid carcinoma (HP:0002895) | 1.88606261 |
| 69 | Acute myeloid leukemia (HP:0004808) | 1.88604227 |
| 70 | Blue irides (HP:0000635) | 1.88384582 |
| 71 | Heterotopia (HP:0002282) | 1.87892781 |
| 72 | Protruding tongue (HP:0010808) | 1.86952393 |
| 73 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.86361675 |
| 74 | Genetic anticipation (HP:0003743) | 1.86119744 |
| 75 | Dysostosis multiplex (HP:0000943) | 1.85761358 |
| 76 | Aortic aneurysm (HP:0004942) | 1.84995445 |
| 77 | Neonatal short-limb short stature (HP:0008921) | 1.83120198 |
| 78 | Congenital glaucoma (HP:0001087) | 1.82634206 |
| 79 | Intrahepatic cholestasis (HP:0001406) | 1.79973539 |
| 80 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.79688746 |
| 81 | Resting tremor (HP:0002322) | 1.79360335 |
| 82 | Chronic hepatic failure (HP:0100626) | 1.79116275 |
| 83 | Pulmonic stenosis (HP:0001642) | 1.78392546 |
| 84 | Menstrual irregularities (HP:0000858) | 1.77608018 |
| 85 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.76857134 |
| 86 | Generalized hypopigmentation of hair (HP:0011358) | 1.76743224 |
| 87 | Obstructive sleep apnea (HP:0002870) | 1.76001946 |
| 88 | Decreased lacrimation (HP:0000633) | 1.75538203 |
| 89 | Sparse lateral eyebrow (HP:0005338) | 1.75221014 |
| 90 | Oligomenorrhea (HP:0000876) | 1.74818549 |
| 91 | Shawl scrotum (HP:0000049) | 1.74052702 |
| 92 | Tubular atrophy (HP:0000092) | 1.73886925 |
| 93 | Bell-shaped thorax (HP:0001591) | 1.73794133 |
| 94 | Metaphyseal dysplasia (HP:0100255) | 1.73164642 |
| 95 | Cystic hygroma (HP:0000476) | 1.72383826 |
| 96 | Hand muscle atrophy (HP:0009130) | 1.72296777 |
| 97 | Hyporeflexia of lower limbs (HP:0002600) | 1.71709046 |
| 98 | Vitreoretinal degeneration (HP:0000655) | 1.71565220 |
| 99 | Broad palm (HP:0001169) | 1.71435887 |
| 100 | Arterial tortuosity (HP:0005116) | 1.70954399 |
| 101 | Deep philtrum (HP:0002002) | 1.70891367 |
| 102 | Upper limb amyotrophy (HP:0009129) | 1.70753895 |
| 103 | Distal upper limb amyotrophy (HP:0007149) | 1.70753895 |
| 104 | Insulin resistance (HP:0000855) | 1.70117347 |
| 105 | Severe Myopia (HP:0011003) | 1.70098741 |
| 106 | Abnormality of the labia majora (HP:0012881) | 1.70013438 |
| 107 | Hip dysplasia (HP:0001385) | 1.69996668 |
| 108 | Rhinitis (HP:0012384) | 1.69024289 |
| 109 | Long eyelashes (HP:0000527) | 1.68081807 |
| 110 | Thick eyebrow (HP:0000574) | 1.66560336 |
| 111 | Fair hair (HP:0002286) | 1.66152909 |
| 112 | Abnormality of the fingertips (HP:0001211) | 1.66084807 |
| 113 | Cerebral inclusion bodies (HP:0100314) | 1.65327711 |
| 114 | Enlarged penis (HP:0000040) | 1.63954247 |
| 115 | Short thorax (HP:0010306) | 1.63318220 |
| 116 | Urethral obstruction (HP:0000796) | 1.63059741 |
| 117 | Aortic regurgitation (HP:0001659) | 1.62861132 |
| 118 | Abnormal foot bone ossification (HP:0010675) | 1.62002298 |
| 119 | Exostoses (HP:0100777) | 1.60568412 |
| 120 | Hypopigmentation of the fundus (HP:0007894) | 1.60438363 |
| 121 | Germ cell neoplasia (HP:0100728) | 1.59537063 |
| 122 | Cystic liver disease (HP:0006706) | 1.59519715 |
| 123 | Hypoplasia of the iris (HP:0007676) | 1.59388337 |
| 124 | Global brain atrophy (HP:0002283) | 1.59091373 |
| 125 | Short middle phalanx of finger (HP:0005819) | 1.59049342 |
| 126 | Thoracolumbar scoliosis (HP:0002944) | 1.58713256 |
| 127 | Cervical subluxation (HP:0003308) | 1.58337425 |
| 128 | Narrow palate (HP:0000189) | 1.57454526 |
| 129 | Protrusio acetabuli (HP:0003179) | 1.57207350 |
| 130 | Neoplasm of the heart (HP:0100544) | 1.56961809 |
| 131 | Prominent forehead (HP:0011220) | 1.56728899 |
| 132 | Broad metatarsal (HP:0001783) | 1.56645416 |
| 133 | Tapered finger (HP:0001182) | 1.55601995 |
| 134 | Buphthalmos (HP:0000557) | 1.55362148 |
| 135 | Dysmetric saccades (HP:0000641) | 1.55174951 |
| 136 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.54307388 |
| 137 | Widely spaced teeth (HP:0000687) | 1.53881561 |
| 138 | Severe short stature (HP:0003510) | 1.53639372 |
| 139 | Wide nose (HP:0000445) | 1.53568040 |
| 140 | Vascular tortuosity (HP:0004948) | 1.53475131 |
| 141 | Open mouth (HP:0000194) | 1.52733368 |
| 142 | Neonatal hypoglycemia (HP:0001998) | 1.52576274 |
| 143 | Exotropia (HP:0000577) | 1.52521152 |
| 144 | Chronic bronchitis (HP:0004469) | 1.52363555 |
| 145 | Limb hypertonia (HP:0002509) | 1.52275387 |
| 146 | Alacrima (HP:0000522) | 1.52007782 |
| 147 | Abnormality of the frontal sinuses (HP:0002687) | 1.51825500 |
| 148 | Short chin (HP:0000331) | 1.51360852 |
| 149 | Back pain (HP:0003418) | 1.51181198 |
| 150 | Abnormality of chloride homeostasis (HP:0011422) | 1.51113102 |
| 151 | Hypoplastic scapulae (HP:0000882) | 1.50545598 |
| 152 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.50545598 |
| 153 | Action tremor (HP:0002345) | 1.50543400 |
| 154 | Tibial bowing (HP:0002982) | 1.50506054 |
| 155 | Advanced eruption of teeth (HP:0006288) | 1.50117521 |
| 156 | Enlarged kidneys (HP:0000105) | 1.50102452 |
| 157 | Mitral valve prolapse (HP:0001634) | 1.50092285 |
| 158 | Mitral stenosis (HP:0001718) | 1.50004488 |
| 159 | Truncal obesity (HP:0001956) | 1.49098792 |
| 160 | Visual hallucinations (HP:0002367) | 1.48901457 |
| 161 | Hepatoblastoma (HP:0002884) | 1.47710292 |
| 162 | Infantile muscular hypotonia (HP:0008947) | 1.47696471 |
| 163 | Abnormality of renin-angiotensin system (HP:0000847) | 1.47256265 |
| 164 | Pigmentary retinal degeneration (HP:0001146) | 1.47163100 |
| 165 | Cubitus valgus (HP:0002967) | 1.47011547 |
| 166 | Thin bony cortex (HP:0002753) | 1.46976404 |
| 167 | Bundle branch block (HP:0011710) | 1.46878673 |
| 168 | Shallow orbits (HP:0000586) | 1.46816692 |
| 169 | Volvulus (HP:0002580) | 1.46496618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.43718169 |
| 2 | FRK | 3.46496358 |
| 3 | TAOK3 | 3.35706829 |
| 4 | MAP3K2 | 2.98433008 |
| 5 | CAMK1G | 2.50666818 |
| 6 | LATS1 | 2.44213613 |
| 7 | STK38L | 2.41572772 |
| 8 | SIK1 | 2.41416407 |
| 9 | CAMK1D | 2.28666809 |
| 10 | CASK | 2.14059001 |
| 11 | PRKD3 | 1.97179052 |
| 12 | ERN1 | 1.93044842 |
| 13 | AKT3 | 1.89334964 |
| 14 | PDGFRA | 1.89298630 |
| 15 | NTRK3 | 1.78025803 |
| 16 | STK39 | 1.76152576 |
| 17 | TRPM7 | 1.71628565 |
| 18 | RIPK1 | 1.61122195 |
| 19 | TRIB3 | 1.57183507 |
| 20 | EPHA2 | 1.54827531 |
| 21 | CDK12 | 1.49270164 |
| 22 | NLK | 1.43781018 |
| 23 | PTK6 | 1.42414606 |
| 24 | ACVR1B | 1.42178958 |
| 25 | BMPR1B | 1.36961037 |
| 26 | PTK2 | 1.35043189 |
| 27 | HIPK2 | 1.34211586 |
| 28 | NTRK1 | 1.29187777 |
| 29 | PAK3 | 1.28150747 |
| 30 | CDC42BPA | 1.27570673 |
| 31 | PASK | 1.27561510 |
| 32 | WNK1 | 1.25107841 |
| 33 | BRD4 | 1.25084322 |
| 34 | FER | 1.24602439 |
| 35 | PRKCH | 1.23524650 |
| 36 | DDR2 | 1.18921244 |
| 37 | SCYL2 | 1.15807857 |
| 38 | MAP3K4 | 1.13096126 |
| 39 | JAK1 | 1.12477794 |
| 40 | SGK3 | 1.11937408 |
| 41 | MYLK | 1.10031779 |
| 42 | WNK4 | 1.09637999 |
| 43 | PIK3CA | 1.08885988 |
| 44 | NUAK1 | 1.08022331 |
| 45 | FGFR2 | 1.07569184 |
| 46 | RET | 1.05731004 |
| 47 | DMPK | 1.05424594 |
| 48 | EIF2AK3 | 1.03890840 |
| 49 | EPHA3 | 1.03656215 |
| 50 | PDGFRB | 0.98984136 |
| 51 | MTOR | 0.97639473 |
| 52 | SGK2 | 0.96159368 |
| 53 | TTN | 0.95171011 |
| 54 | MAPK15 | 0.94882758 |
| 55 | FGFR3 | 0.94789555 |
| 56 | NEK6 | 0.92113834 |
| 57 | EEF2K | 0.91795080 |
| 58 | IRAK3 | 0.90894623 |
| 59 | MAP3K1 | 0.89624613 |
| 60 | MAP3K3 | 0.88424628 |
| 61 | MET | 0.86604395 |
| 62 | FGFR4 | 0.85462482 |
| 63 | MAP3K6 | 0.84084955 |
| 64 | CAMKK2 | 0.82620530 |
| 65 | PRKD2 | 0.82246875 |
| 66 | LMTK2 | 0.80483392 |
| 67 | DAPK2 | 0.76952998 |
| 68 | PIK3CG | 0.75458557 |
| 69 | CAMKK1 | 0.74500803 |
| 70 | MST4 | 0.72069437 |
| 71 | MAP3K9 | 0.71636734 |
| 72 | PRKAA1 | 0.71346310 |
| 73 | MELK | 0.70680696 |
| 74 | BCR | 0.70071467 |
| 75 | MARK2 | 0.68997650 |
| 76 | SGK1 | 0.67809049 |
| 77 | RIPK4 | 0.66998555 |
| 78 | SGK494 | 0.66197995 |
| 79 | SGK223 | 0.66197995 |
| 80 | MST1R | 0.65895570 |
| 81 | PKN2 | 0.65739694 |
| 82 | TNIK | 0.65620660 |
| 83 | STK24 | 0.65615032 |
| 84 | OXSR1 | 0.65539385 |
| 85 | TNK2 | 0.65021165 |
| 86 | MKNK2 | 0.64756067 |
| 87 | MAP2K4 | 0.63960417 |
| 88 | STK38 | 0.63170145 |
| 89 | JAK2 | 0.62683720 |
| 90 | PRKD1 | 0.62500654 |
| 91 | PRKAA2 | 0.62462292 |
| 92 | BRSK2 | 0.61856333 |
| 93 | PNCK | 0.61373773 |
| 94 | CSNK1E | 0.59563800 |
| 95 | DYRK1B | 0.58097762 |
| 96 | EPHB1 | 0.57036390 |
| 97 | KSR2 | 0.56764706 |
| 98 | WNK3 | 0.56705458 |
| 99 | FLT3 | 0.56667644 |
| 100 | MAP3K7 | 0.56237805 |
| 101 | SIK2 | 0.55367252 |
| 102 | PDPK1 | 0.52557862 |
| 103 | RPS6KA2 | 0.51570963 |
| 104 | PRKCE | 0.51435944 |
| 105 | ICK | 0.49886065 |
| 106 | TEC | 0.44188975 |
| 107 | RPS6KA3 | 0.44052187 |
| 108 | MAPK8 | 0.43934621 |
| 109 | KSR1 | 0.43566648 |
| 110 | IGF1R | 0.42861087 |
| 111 | CDK5 | 0.42346203 |
| 112 | STK3 | 0.42319124 |
| 113 | MAPK10 | 0.42199733 |
| 114 | GSK3B | 0.41398545 |
| 115 | MAPK1 | 0.41374634 |
| 116 | CAMK2D | 0.41246871 |
| 117 | MAPK14 | 0.40340932 |
| 118 | RPS6KB1 | 0.40102587 |
| 119 | STK11 | 0.40016230 |
| 120 | EPHA4 | 0.39937673 |
| 121 | PAK2 | 0.39062926 |
| 122 | MAP3K10 | 0.38613208 |
| 123 | FGFR1 | 0.37549405 |
| 124 | ERBB2 | 0.37113345 |
| 125 | CHUK | 0.37038643 |
| 126 | CDK3 | 0.36858994 |
| 127 | GSK3A | 0.36805712 |
| 128 | PAK6 | 0.36048380 |
| 129 | ROCK1 | 0.35675359 |
| 130 | NEK9 | 0.35355040 |
| 131 | PDK1 | 0.33924193 |
| 132 | CAMK1 | 0.33826857 |
| 133 | ATM | 0.33271835 |
| 134 | PTK2B | 0.31112034 |
| 135 | TYRO3 | 0.30602621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.17339596 |
| 2 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.32394716 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 2.24981987 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.90142721 |
| 5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.83946558 |
| 6 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.45673058 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43545600 |
| 8 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.36179421 |
| 9 | Lysine degradation_Homo sapiens_hsa00310 | 1.34738403 |
| 10 | Protein export_Homo sapiens_hsa03060 | 1.32356072 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 1.31359402 |
| 12 | Insulin resistance_Homo sapiens_hsa04931 | 1.30610952 |
| 13 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.26603753 |
| 14 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.24205674 |
| 15 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.22984399 |
| 16 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.21931911 |
| 17 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.18620913 |
| 18 | ABC transporters_Homo sapiens_hsa02010 | 1.18098971 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.16999125 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.16408633 |
| 21 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.16186035 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.14242164 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.13714030 |
| 24 | Tight junction_Homo sapiens_hsa04530 | 1.13117888 |
| 25 | Long-term potentiation_Homo sapiens_hsa04720 | 1.12536096 |
| 26 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.12041632 |
| 27 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.11047761 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.10148901 |
| 29 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.06174937 |
| 30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05494354 |
| 31 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.02893744 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.01853870 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.01752507 |
| 34 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.00659966 |
| 35 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.00612820 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99661531 |
| 37 | Axon guidance_Homo sapiens_hsa04360 | 0.99584596 |
| 38 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99222849 |
| 39 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98321284 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 0.96910222 |
| 41 | Circadian entrainment_Homo sapiens_hsa04713 | 0.96692229 |
| 42 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.96237958 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94696811 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92315253 |
| 45 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.92089184 |
| 46 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.90706815 |
| 47 | Salivary secretion_Homo sapiens_hsa04970 | 0.89377177 |
| 48 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.88877527 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88702505 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 0.88354705 |
| 51 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.87502403 |
| 52 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87318609 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.87257600 |
| 54 | Taste transduction_Homo sapiens_hsa04742 | 0.85443106 |
| 55 | GABAergic synapse_Homo sapiens_hsa04727 | 0.84735701 |
| 56 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.84192218 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83527837 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.83481821 |
| 59 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.83475954 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83196207 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82472166 |
| 62 | Adherens junction_Homo sapiens_hsa04520 | 0.82393926 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82300682 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.82123379 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81957178 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81798545 |
| 67 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81388709 |
| 68 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.80257159 |
| 69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.80136393 |
| 70 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.79782934 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.77792838 |
| 72 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.77639323 |
| 73 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76864574 |
| 74 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76125623 |
| 75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.75958236 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.75825721 |
| 77 | Focal adhesion_Homo sapiens_hsa04510 | 0.75029320 |
| 78 | Long-term depression_Homo sapiens_hsa04730 | 0.74190810 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.74046777 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73538753 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.73247816 |
| 82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.73191880 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.72619936 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.72415185 |
| 85 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.72326620 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.72198930 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71709126 |
| 88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71423068 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71326347 |
| 90 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.70981366 |
| 91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70967773 |
| 92 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70873269 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70864775 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69477039 |
| 95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69077087 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68332882 |
| 97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.67220363 |
| 98 | Morphine addiction_Homo sapiens_hsa05032 | 0.66375647 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.66239818 |
| 100 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.65774195 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65608572 |
| 102 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.65371162 |
| 103 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65091002 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64557481 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64543190 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64398785 |
| 107 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63334224 |
| 108 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62877939 |
| 109 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62781206 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.62683595 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61858580 |
| 112 | Platelet activation_Homo sapiens_hsa04611 | 0.60878413 |
| 113 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60795701 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60399109 |
| 115 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59833751 |
| 116 | Melanogenesis_Homo sapiens_hsa04916 | 0.59337736 |
| 117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58974878 |
| 118 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58634001 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58206608 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.57807899 |
| 121 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.57734432 |
| 122 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57334082 |
| 123 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57071844 |
| 124 | Melanoma_Homo sapiens_hsa05218 | 0.56828733 |
| 125 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.56457218 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56100204 |
| 127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55980561 |
| 128 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54151075 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53814046 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53493847 |
| 131 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52900372 |
| 132 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.52671558 |
| 133 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.51891200 |
| 134 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49758197 |
| 135 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46974331 |
| 136 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46890850 |
| 137 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.46265530 |

